329 related articles for article (PubMed ID: 25380841)
21. Inflammation, high ferritin, and erythropoietin resistance in indigenous maintenance hemodialysis patients from the Top End of Northern Australia.
Majoni SW; Ellis JA; Hall H; Abeyaratne A; Lawton PD
Hemodial Int; 2014 Oct; 18(4):740-50. PubMed ID: 24766376
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of Reticulocyte Hemoglobin Equivalent in Management of Regular Hemodialysis Patients with Iron Deficiency Anemia.
Dalimunthe NN; Lubis AR
Rom J Intern Med; 2016; 54(1):31-6. PubMed ID: 27141568
[TBL] [Abstract][Full Text] [Related]
23. Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients.
Bataille S; Pelletier M; Sallée M; Berland Y; McKay N; Duval A; Gentile S; Mouelhi Y; Brunet P; Burtey S
BMC Nephrol; 2017 Jul; 18(1):251. PubMed ID: 28747155
[TBL] [Abstract][Full Text] [Related]
24. Distortion of iron status indices by acute inflammation in older hospitalized patients.
Cunietti E; Chiari MM; Monti M; Engaddi I; Berlusconi A; Neri MC; De Luca P
Arch Gerontol Geriatr; 2004; 39(1):35-42. PubMed ID: 15158579
[TBL] [Abstract][Full Text] [Related]
25. Can serum NGAL levels be used as an inflammation marker on hemodialysis patients with permanent catheter?
Yigit IP; Celiker H; Dogukan A; Ilhan N; Gurel A; Ulu R; Aygen B
Ren Fail; 2015 Feb; 37(1):77-82. PubMed ID: 25347233
[TBL] [Abstract][Full Text] [Related]
26. Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients.
Bradbury BD; Critchlow CW; Weir MR; Stewart R; Krishnan M; Hakim RH
Nephrol Dial Transplant; 2009 Mar; 24(3):919-25. PubMed ID: 18840893
[TBL] [Abstract][Full Text] [Related]
27. The effect of serum albumin level on iron-induced oxidative stress in chronic renal failure patients.
Sezer MT; Akin H; Demir M; Erturk J; Aydin ZD; Savik E; Tunc N
J Nephrol; 2007; 20(2):196-203. PubMed ID: 17514624
[TBL] [Abstract][Full Text] [Related]
28. Does Helicobacter pylori infection play a role in iron deficiency anemia in hemodialysis patients?
El-Said H; Attallah AHB; Ali-Eldin ZA
Clin Nephrol; 2017 Oct; 88(10):177-180. PubMed ID: 28699885
[TBL] [Abstract][Full Text] [Related]
29. Screening for Iron Deficiency in Early Childhood Using Serum Ferritin in the Primary Care Setting.
Oatley H; Borkhoff CM; Chen S; Macarthur C; Persaud N; Birken CS; Maguire JL; Parkin PC;
Pediatrics; 2018 Dec; 142(6):. PubMed ID: 30487142
[TBL] [Abstract][Full Text] [Related]
30. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
Riedel MK; Morgenstern T
Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
[TBL] [Abstract][Full Text] [Related]
31. Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III: prevalence and associations with anemia and inflammation.
Parikh A; Natarajan S; Lipsitz SR; Katz SD
Circ Heart Fail; 2011 Sep; 4(5):599-606. PubMed ID: 21705484
[TBL] [Abstract][Full Text] [Related]
32. Measurement of the serum levels of serum troponins I and T, albumin and C-Reactive protein in chronic hemodialysis patients and their relationship with left ventricular hypertrophy and heart failure.
Forghani MS; Jadidoleslami MS; Naleini SN; Rajabnia M
Diabetes Metab Syndr; 2019; 13(1):522-525. PubMed ID: 30641758
[TBL] [Abstract][Full Text] [Related]
33. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
[TBL] [Abstract][Full Text] [Related]
34. Hepcidin-25, mean corpuscular volume, and ferritin as predictors of response to oral iron supplementation in hemodialysis patients.
Takasawa K; Takaeda C; Maeda T; Ueda N
Nutrients; 2014 Dec; 7(1):103-18. PubMed ID: 25551249
[TBL] [Abstract][Full Text] [Related]
35. Comparison of two iron gluconate treatment modalities in chronic hemodialysis patients: results of a randomized trial.
Giordano A; Arrigo G; Lavarda F; Colasanti G; Petrini C
J Nephrol; 2005; 18(2):181-7. PubMed ID: 15931646
[TBL] [Abstract][Full Text] [Related]
36. Transferrin saturation versus reticulocyte hemoglobin content for iron deficiency in Japanese hemodialysis patients.
Kaneko Y; Miyazaki S; Hirasawa Y; Gejyo F; Suzuki M
Kidney Int; 2003 Mar; 63(3):1086-93. PubMed ID: 12631092
[TBL] [Abstract][Full Text] [Related]
37. Clinical interpretation of reticulocyte hemoglobin content, RET-Y, in chronic hemodialysis patients.
Ng HY; Chen HC; Pan LL; Tsai YC; Hsu KT; Liao SC; Chuang FR; Chen JB; Lee CT
Nephron Clin Pract; 2009; 111(4):c247-52. PubMed ID: 19293593
[TBL] [Abstract][Full Text] [Related]
38. Early detection of iron deficiency in elite athletes: could microcytic anemia factor (Maf) be useful?
Dopsaj V; Martinovic J; Dopsaj M
Int J Lab Hematol; 2014 Feb; 36(1):37-44. PubMed ID: 23731862
[TBL] [Abstract][Full Text] [Related]
39. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
40. Effect of anemia and hyperhomocysteinemia on mortality of patients on hemodialysis.
Anees M; Mumtaz A; Ibrahim M; Shaheen SM; Asghar A
Iran J Kidney Dis; 2010 Jan; 4(1):60-5. PubMed ID: 20081306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
